NY Federal Court Won't Rethink Cymbalta Labeling Suit
A New York federal judge on Thursday declined to review a suit against Eli Lilly & Co. over the labeling of its antidepressant Cymbalta that allegedly downplays its withdrawal symptoms, finding...To view the full article, register now.
Already a subscriber? Click here to view full article